You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immunoconjugate

Showing 1 - 25 of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With

Recruiting
  • Pancreatic Cancer
  • +4 more
  • PET Scan
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 10, 2023

Acute Lymphoblastic Leukemia Treated With Anti-CD22

Recruiting
  • Acute Lymphoblastic Leukemia
  • Anti-CD22 Immunotoxin
  • Meldola (FC), FC, Italy
  • +4 more
Feb 25, 2021

B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

Recruiting
  • B-cell Lymphoma
  • +8 more
  • Polatuzumab vedotin
  • Valhalla, New York
    New York Medical Center
Oct 29, 2021

Anatomic Stage IV Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Yuma, Arizona
  • +5 more
May 25, 2022

Multiple Myeloma Trial (Belantamab mafodotin (GSK2857916) anti-BCMA-immunoconjugate)

Approved for marketing
  • Multiple Myeloma
  • Belantamab mafodotin (GSK2857916) anti-BCMA-immunoconjugate
  • (no location specified)
Mar 9, 2021

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

Completed
Has Results
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 22, 2022

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

Recruiting
  • Metastatic Salivary Gland Carcinoma
  • +4 more
  • New York, New York
    Memorial Sloane Kettering Cancer Center
Jan 11, 2023

NSCLC Trial in Cleveland, Houston (L-DOS47)

Completed
  • Non-Small Cell Lung Cancer
  • Cleveland, Ohio
  • +1 more
Feb 20, 2020

Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

Recruiting
  • Breast Adenocarcinoma
  • +7 more
  • Multi-epitope HER2 Peptide Vaccine TPIV100
  • +5 more
  • Scottsdale, Arizona
  • +26 more
Aug 17, 2022

NSCLC Trial in Otwock, Poznan, Warsaw (L-DOS47)

Completed
  • Non-Small Cell Lung Cancer
  • Otwock, Poland
  • +4 more
Mar 13, 2019

Multiple Myeloma Trial in United States (Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • San Francisco, California
  • +5 more
Dec 9, 2022

Hodgkin Lymphoma Trial in Italy (Tislelizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Alessandria, IT, Italy
  • +9 more
Aug 4, 2023

Multiple Myeloma, Myeloma, Plasma-Cell, PLASMACYTOMA Trial in United States (milatuzumab)

Completed
  • Multiple Myeloma
  • +2 more
  • milatuzumab
  • Atlanta, Georgia
  • +5 more
Aug 12, 2021

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Pancreas Cancer Trial in Scottsdale, Morristown, Milwaukee (L-DOS47, Doxorubicin)

Recruiting
  • Pancreas Cancer
  • Scottsdale, Arizona
  • +2 more
Mar 16, 2022

Refractory Multiple Myeloma Trial in United States (Lintuzumab AC 225)

Terminated
  • Refractory Multiple Myeloma
  • Lintuzumab AC 225
  • Los Angeles, California
  • +4 more
Feb 22, 2022

The Acute Promyelocytic Leukaemia Asian Consortium Project

Recruiting
  • Acute Promyelocytic Leukemia
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Oct 3, 2022

    DLBCL, Diffuse Large B Cell Lymphoma Trial in Worldwide (R-pola-mini-CHP, R-mini-CHOP)

    Recruiting
    • DLBCL
    • Diffuse Large B Cell Lymphoma
    • Aalborg, Denmark
    • +44 more
    Jul 8, 2021

    Novo Acute Myeloid Leukemia Trial in Spain (Mylotarg)

    Completed
    Has Results
    • Novo Acute Myeloid Leukemia
    • Badalona, Barcelona, Spain
    • +5 more
    Jan 26, 2021

    Tumors Trial in Herston, Heidelberg (Melbourne) (111-Indium-CMD-193, CMD-193)

    Terminated
    Has Results
    • Neoplasms
    • Herston, Queensland, Australia
    • +1 more
    Jul 27, 2020

    Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

    Recruiting
    • Anatomic Stage II Breast Cancer AJCC v8
    • +8 more
    • Birmingham, Alabama
    • +911 more
    Aug 23, 2022

    Leukemia Trial in Houston (Mylotarg)

    Terminated
    • Leukemia
    • Houston, Texas
      UT MD Anderson Cancer Center
    Oct 30, 2018

    Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +49 more
    • Birmingham, Alabama
    • +1429 more
    Aug 17, 2022

    HER2/Neu Positive, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer Trial in Seattle (Laboratory Biomarker Analysis,

    Completed
    • HER2/Neu Positive
    • +4 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    May 19, 2017

    Cell Samples From Patients With Acute Myeloid Leukemia

    Completed
    • Leukemia
    • western blotting
    • +2 more
    • (no location specified)
    May 11, 2015